202 related articles for article (PubMed ID: 23019348)
1. Update in TSH receptor agonists and antagonists.
Gershengorn MC; Neumann S
J Clin Endocrinol Metab; 2012 Dec; 97(12):4287-92. PubMed ID: 23019348
[TBL] [Abstract][Full Text] [Related]
2. Small molecule TSHR agonists and antagonists.
Neumann S; Gershengorn MC
Ann Endocrinol (Paris); 2011 Apr; 72(2):74-6. PubMed ID: 21511239
[TBL] [Abstract][Full Text] [Related]
3. A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism.
Neumann S; Kleinau G; Costanzi S; Moore S; Jiang JK; Raaka BM; Thomas CJ; Krause G; Gershengorn MC
Endocrinology; 2008 Dec; 149(12):5945-50. PubMed ID: 18669595
[TBL] [Abstract][Full Text] [Related]
4. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.
Sanders J; Miguel RN; Furmaniak J; Smith BR
Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929
[TBL] [Abstract][Full Text] [Related]
5. New small molecule agonists to the thyrotropin receptor.
Latif R; Ali MR; Ma R; David M; Morshed SA; Ohlmeyer M; Felsenfeld DP; Lau Z; Mezei M; Davies TF
Thyroid; 2015 Jan; 25(1):51-62. PubMed ID: 25333622
[TBL] [Abstract][Full Text] [Related]
6. Central dogma in thyroid dysfunction: a review on structure modification of TSHR as a cornerstone for thyroid abnormalities.
Mansourian AR
Pak J Biol Sci; 2011 Feb; 14(3):170-81. PubMed ID: 21870640
[TBL] [Abstract][Full Text] [Related]
7. A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
Neumann S; Huang W; Eliseeva E; Titus S; Thomas CJ; Gershengorn MC
Endocrinology; 2010 Jul; 151(7):3454-9. PubMed ID: 20427476
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule thyrotropin receptor agonist activates naturally occurring thyrotropin-insensitive mutants and reveals their distinct cyclic adenosine monophosphate signal persistence.
Allen MD; Neumann S; Gershengorn MC
Thyroid; 2011 Aug; 21(8):907-12. PubMed ID: 21745101
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a Positive Allosteric Modulator of the Thyrotropin Receptor: Potentiation of Thyrotropin-Mediated Preosteoblast Differentiation In Vitro.
Neumann S; Eliseeva E; Boutin A; Barnaeva E; Ferrer M; Southall N; Kim D; Hu X; Morgan SJ; Marugan JJ; Gershengorn MC
J Pharmacol Exp Ther; 2018 Jan; 364(1):38-45. PubMed ID: 29089368
[TBL] [Abstract][Full Text] [Related]
10. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design.
Zhang M; Tong KP; Fremont V; Chen J; Narayan P; Puett D; Weintraub BD; Szkudlinski MW
Endocrinology; 2000 Sep; 141(9):3514-7. PubMed ID: 10965926
[TBL] [Abstract][Full Text] [Related]
11. Targeting thyroid diseases with TSH receptor analogs.
Galofré JC; Chacón AM; Latif R
Endocrinol Nutr; 2013 Dec; 60(10):590-8. PubMed ID: 23538281
[TBL] [Abstract][Full Text] [Related]
12. Human TSH receptor ligands as pharmacological probes with potential clinical application.
Neumann S; Raaka BM; Gershengorn MC
Expert Rev Endocrinol Metab; 2009 Nov; 4(6):669. PubMed ID: 20161662
[TBL] [Abstract][Full Text] [Related]
13. [Peptide 612-627 of thyrotropin receptor and its modified derivatives as the regulators of adenylyl cyclase in the rat thyroid gland].
Shpakov AO; Shpakova EA; Tarasenko II; Derkach KV
Tsitologiia; 2014; 56(7):526-35. PubMed ID: 25696997
[TBL] [Abstract][Full Text] [Related]
14. A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy.
Marcinkowski P; Hoyer I; Specker E; Furkert J; Rutz C; Neuenschwander M; Sobottka S; Sun H; Nazare M; Berchner-Pfannschmidt U; von Kries JP; Eckstein A; Schülein R; Krause G
Thyroid; 2019 Jan; 29(1):111-123. PubMed ID: 30351237
[TBL] [Abstract][Full Text] [Related]
15. The thyrotropin receptor as a model to illustrate receptor and receptor antibody diseases.
Ludgate ME; Vassart G
Baillieres Clin Endocrinol Metab; 1995 Jan; 9(1):95-113. PubMed ID: 7726800
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Action of TSHR Autoantibodies.
Furmaniak J; Sanders J; Núñez Miguel R; Rees Smith B
Horm Metab Res; 2015 Sep; 47(10):735-52. PubMed ID: 26361260
[TBL] [Abstract][Full Text] [Related]
17. A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor.
Neumann S; Eliseeva E; McCoy JG; Napolitano G; Giuliani C; Monaco F; Huang W; Gershengorn MC
J Clin Endocrinol Metab; 2011 Feb; 96(2):548-54. PubMed ID: 21123444
[TBL] [Abstract][Full Text] [Related]
18. Antithyroid Drugs Inactivate TSH Binding to the TSH Receptor by their Reducing Action.
Ochi Y; Hachiya T; Koyama Y; Fukuhori N; Ashida N
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):508-512. PubMed ID: 29468987
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice.
Neumann S; Huang W; Titus S; Krause G; Kleinau G; Alberobello AT; Zheng W; Southall NT; Inglese J; Austin CP; Celi FS; Gavrilova O; Thomas CJ; Raaka BM; Gershengorn MC
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12471-6. PubMed ID: 19592511
[TBL] [Abstract][Full Text] [Related]
20. Targeting the thyrotropin receptor in thyroid disease.
El-Kaissi S; Wall JR
Expert Opin Ther Targets; 2012 Jul; 16(7):719-27. PubMed ID: 22621289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
